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Abstract
Chromosomes have a complex three-dimensional (3D) architecture comprising A/B compartments, topologically associating
domains and promoter–enhancer interactions. At all these levels, the 3D genome has functional consequences for gene
transcription and therefore for cellular identity. The development and activation of lymphocytes involves strict control of
gene expression by transcription factors (TFs) operating in a three-dimensionally organized chromatin landscape. As
lymphocytes are indispensable for tissue homeostasis and pathogen defense, and aberrant lymphocyte activity is involved
in a wide range of human morbidities, acquiring an in-depth understanding of the molecular mechanisms that control
lymphocyte identity is highly relevant. Here we review current knowledge of the interplay between 3D genome organization
and transcriptional control during B and T lymphocyte development and antigen-dependent activation, placing special
emphasis on the role of TFs.
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Introduction
Thedevelopment and activation of immune cells has long served
as a paradigm for studying transcriptional control during cell
differentiation. Three-dimensional (3D) folding of the genome
is implicated in the control of gene expression and cell fate,
including for cells of the immune system.Our immune system is
indispensable for host defense and tissue repair, for it eliminates
pathogens, clears malignant cells and maintains tissue home-
ostasis. In vertebrates, the immune system is composed of a
plethora of cell types with different and often highly specialized
functions. Together and through their interplay with various
other types of cells (e.g. stromal or epithelial cells), immune
cells orchestrate two complementary types of responses: imme-
diate and broadly effective responses (‘innate immunity’) as
well as antigen-specific, long-lasting responses that generate
immunological memory (‘adaptive immunity’). B and T Lym-
phocytes are central in mounting effective adaptive immune
responses, and lymphocyte development and activity are gov-
erned by strict transcriptional control of cell lineage progression,
cell identity and function. Importantly, impaired transcriptional
control in lymphocytes can lead to aberrant immune cell devel-
opment or activity, as seen in a wide variety of disorders that
includes (hematological) cancers, immunodeficiencies, asthma
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and autoimmune diseases. Here we summarize our current
knowledge of the molecular mechanisms that regulate gene
expression in immune cells,with focus on the interplay between
3D genome organization and transcriptional control in lympho-
cyte development and activation.
Transcriptional regulation occurs in 3D
Cell-type or cell-state-specific gene expression is critically regu-
lated by transcription factors (TFs), a class of sequence-specific
DNA-binding proteins [1]. TFs regulate transcription by binding
to gene regulatory elements (REs) in promoters (the region pre-
ceding the transcription start site, or TSS) and often distantly
located REs called enhancers. They recruit cofactors (including
coactivators, corepressors) to modify the local chromatin land-
scape and facilitate or impede the recruitment of the RNA poly-
merase 2 (RNAPol2) basal transcription machinery [1, 2]. Con-
versely, the chromatin state strongly influences DNA binding of
TFs, for the positioning and post-translational modifications of
the nucleosomes aroundwhich genomic DNA iswrapped dictate
DNA accessibility for TFs [3]. A subset of TFs has the capacity
to bind ‘inaccessible’ chromatin and these are often referred to
as ‘pioneer’ factors [4]. Many lineage-determining TFs appear to
have such pioneering capacities [5].
For our own convenience, we think of our genome as a one-
dimensional string of chromatin on which genes and REs are
linearly separated. However, chromosomes display a complex
3D architecture, which has been intensively studied the past
20 years and has functional consequences for almost all DNA-
templated processes, including transcriptional regulation [6].
Early studies of how enhancers regulate spatiotemporal expres-
sion of their target loci over large distances led to proposed
models inwhich 3D folding allows spatial and specific proximity,
regardless of linear distance, between promoter–enhancer pairs
[7–9]. Technologies to document 3D genome architecture and its
dynamics have evolved rapidly over the past years. They now
enable researchers to look beyond the properties and folding of
individual gene loci, i.e. at gene clusters, but also at megabase-
sized chromosomes. The high-throughput chromosome confor-
mation capture (3C) assay and its subsequent 4C, 5C and Hi-C
protocols have been particularly groundbreaking [10]. Their use
has resulted in a multi-layered model of genome conformation
that indeed goes beyond local interactions between genes and
their respective enhancers, with strong links to transcriptional
activity at every layer (Figure 1). 3D-folded genomes, as
chromosomes, segregate into two major compartments based
on chromatin state. Highly accessible regions are marked by
histone modifications associated with regulatory activity (e.g.
histone-3 lysine-4 dimethylation, H3K4me2; histone-3 lysine-
27 acetylation, H3K27ac) and group together, whereas regions
of low accessibility are marked by repressive histone marks
(e.g. H3K9me3 or H3K27me3) and cluster separately [11]. These
compartments are arbitrarily referred to as the A (‘active’) and B
(‘inactive’) compartments, respectively. As expected from their
different chromatin landscapes, the average gene expression
levels are substantially higher in the A compartment [12]. At
a smaller scale (∼200 to 2000 kilobases), genomic regions are
organized into domains of high self-interaction frequencies,
named topologically associating domains [13–15]. TADs insulate
genomic regions, which is thought to facilitate the frequency
and specificity of intra-TAD promoter–RE interactions. Indeed,
genes and REs mapped within the same TAD are more likely
to find each other in 3D than when located in different
TADs [16] (Figure 1).
Multiple forces appear to play a key role in the forma-
tion of A versus B compartments, TADs and promoter–RE
interactions (for recent reviews, see [9, 17–19]). Prominent
amongst these is loop extrusion, in which the ring-shaped
cohesin complex extrudes chromatin to form loops until it
is blocked by the DNA-binding protein CCCTC-binding factor
(CTCF). The process of transcription has been implicated
in shaping genome topology at various levels [17, 19]. TFs
have also been directly implicated in shaping various aspects
of 3D genome folding, including the establishment and
maintenance of intra-TAD promoter–enhancer interactions
[18, 20, 21]. Overall, 3D genome architecture displays cell-
type or cell-state-specific features [22, 23], suggesting that
genome conformation is linked to specific gene expression
programs. Indeed, changes in 3D genome folding appear
dynamically coupled to changes in chromatin landscape,
but also TF-DNA binding and hence gene expression [24].
However, it should be noted that the causal relationships
between all these aspects of genome function and control—
particularly for 3D genome organization and transcription—
are highly complex and only partially understood (reviewed
in [17]). While inhibition of transcription can affect genome
conformation, TADs and compartments can be established or
maintained in the absence of transcription or RNAPol2 [17, 25,
26]. Nevertheless, perturbation of genome topology is able to
induce altered gene expression [27–31], although the extent
of this appears dependent on cell state. Surprisingly, global
depletion of CTCF or cohesin—resulting in a loss of nearly all
TADs—does not necessarily cause widespread transcriptional
misregulation under steady-state conditions [29–32]. On the
other hand, various developmentally regulated loci (e.g. Sox9,
genes of the Hoxd cluster, IHH) show major transcriptional
defects upon perturbation of their respective TAD(s) [27, 33,
34]. Interestingly, post-mitotic macrophages lacking RAD21 (an
essential component of the cohesin complex) do not display
severe transcriptional defects until they are stimulated with
endotoxin [35], illustrating that 3D genome architecture may
be particularly important to rapidly modify gene expression
programs.
Immune cell identity and function relies on accurate
transcriptional control
A cell’s phenotype is determined by its gene expression
program. Thus, substantial transcriptional changes are required
for immune cells to adapt to instructive cues in their envi-
ronment (e.g. during differentiation or activation). In mam-
mals, most immune cells are derived from bone marrow
resident hematopoietic stem cells that differentiate guided
by signals emanating from the tissue microenvironment
[36]. As hematopoietic stem cells differentiate and mature, a
first major lineage bifurcation into either common myeloid
progenitors (CMPs) or common lymphoid progenitors (CLPs)
occurs. In addition to thrombocytes (for coagulation) and
erythrocytes (for oxygen transport), CMPs give rise to a
variety of innate immune cells, including mast cells, neu-
trophils, basophils, eosinophils, monocytes and dendritic
cells. CLPs give rise to the B and T lymphocytes of the
adaptive immune system, as well as innate lymphoid cells
including natural killer cells [36–38]. With such a diversity
of cell types originating from a common progenitor, tight
transcriptional control is critical to ensure a correct qualitative
and quantitative cellular output as well as stable lineage
fidelity.
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Figure 1. Key features of 3D genome organization. (A) Spatial chromosome folding in the nucleus separates the genome into two compartments: the A compartment that
mainly consists of active genes and euchromatin (yellow spheres), and the B compartment that is enriched for inactive genes and heterochromatin (blue spheres).While
regions of the A compartment localize to the nuclear interior, B compartment domains reside near the nuclear lamina. (B) A/B compartments contain megabase-sized
self-interacting regions called topologically associating domains (TADs, depicted here as individual spheres). TADs tend to have a uniform compartment association
and are separated by border regions. (C) TADs are considered functional units of chromosome organization in which enhancers (shown as boxes marked with ‘E’)
interact with genes or other REs to control transcription. TAD border insulation is thought to restrict the search space of enhancers and promoters and to prevent
unwanted regulatory contacts to be formed.
Developing B and T lymphocytes undergo a rigid, stepwise
differentiation process involving combinatorial TF action that
is intimately connected to the lineage-specific, ordered gene
rearrangements occurring at their antigen-receptor loci (Figure
2A). B and T cells have the unique capacity to specifically recog-
nize foreign antigens based on surface expression of the B-cell
receptor (BCR) and T-cell receptor (TCR), respectively. Whereas
the BCR is composed of identical pairs of immunoglobulin (Ig)
heavy (H) chains and light (L) chains (the latter of the κ or λ
subtype), TCRs are dimers that consists of either an α and β chain
or a γ and δ chain. The antigen-specific variable domains of the
Ig/TCR chains are encoded by arrays of various gene segments—
so called variable (V), diversity (D) and joining (J) segments—
that are genetically recombined in a largely random fashion.
Both in B cells and in T cells, the gene rearrangement events
are initiated through the activity of the recombination activating
gene (RAG1/RAG2) proteins [39]. Because of the very large num-
ber of unique possible combinations of this ‘VDJ-recombination’
process (often estimated at >1011 [40]) and additional processes
for nucleotide sequence diversification (e.g. somatic hypermu-
tation) in B cells, mammals are able to generate BCRs and TCRs
against virtually any antigen [39]. Once mature and checked
for autoreactivity, immune cells are highly receptive to exter-
nal signals for their rapid activation or further specification
toward effector cells, which are actively involved in pathogen
destruction or tissue repair [41–43]. Upon antigen recognition
by the BCR and appropriate T-cell costimulation in germinal
centers, B cells either further differentiate into plasma cells that
produce pathogen-neutralizing antibodies (secreted forms of the
BCR) or into long-lasting circulating memory B cells [44]. When
activated by antigen-presenting cells, T cells fulfill a wide range
of essential immune functions, ranging from the destruction of
virus-infected or malignant cells (by cytotoxic CD8+ T cells) to
orchestrating tailor-made local immune responses through the
production of cytokines (by helper CD4+ T cells).
Throughout their development and activation, the exposure
of immune cells to environmental cues (e.g. cytokines, metabo-
lites, cell-cell interactions) triggers a cell-intrinsic signal trans-
duction cascade that converges on altered expression and/or
activity of DNA-binding TFs [1]. TFs in turn drive and coor-
dinate the transcriptional changes required for immune cell-
fate determination and lineage progression or for triggering
specific effector programs in mature immune cells [45–47]. For
example, in the thymus the membrane-bound Delta-family of
ligands on epithelial cells interact with the NOTCH receptors on
lymphoid progenitors. This causes specific proteolytic cleavage
of the receptor, liberating the NOTCH intracellular domain that
accumulates in the nucleus, where it acts as a TF and induces
a T-cell gene expression program [48]. Other classic examples
of how extrinsic signals control immune cell function involve
signal transduction via intracellular Janus kinases (JAKs) and
signal transducer and activator of transcription proteins (STATs).
Activated T cells produce the interleukin-2 (IL-2) cytokine and
concomitantly upregulate IL-2 receptor expression, resulting in
JAK-mediated phosphorylation of STAT5, which then dimerizes
and translocates to the nucleus to activate a cell proliferation
gene expression program [49]. Thus, as endpoints of a signal
transduction cascade, TFs convert signals from a cell’s microen-
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Figure 2. Transcription factors drive 3D genome dynamics during lymphocyte differentiation and activation. (A) Differentiation stages of T (top; for themost common αβ
subset) or B (bottom) lymphocytes as they develop from hematopoietic progenitor cells (HPCs) into mature antigen-receptor-expressing cells that migrate to peripheral
tissues (i.e. lymph nodes and spleen) for their antigen-dependent activation. Selected key transcription factors (TFs) critical for the various cell state transitions
are indicated. Timing of TCR and immunoglobulin (Ig) locus recombination is indicated in blue. Dashed dark gray arrows denote migration of differentiated cells
into the periphery; red arrows are used for antigen-dependent differentiation steps. Additional abbreviations: DN, double-negative; DP, double-positive; SP, single-
positive; ETP, early thymic precursor; Th, T helper cell; Tc, cytotoxic T cell; GC, germinal center. (B) Analyses of topological genome dynamics during T-cell or B-cell
lineage commitment and subsequent activation of mature lymphocytes have shown that the most extensive rewiring of 3D genome organization occurs right after the
appearance of the commitment TFs BCL11b (for T cells) or PAX5 (for B cells) and after antigen-dependent activation. Several TFs critical for T-cell or B-cell activation have
also been implicated in reorganizing lymphocyte genome conformation (e.g. GATA3, MYC). (C) Schematic representation of the interplay between genome topology,
the activation of lineage-determining TFs (LDTF) and the subsequent action of these LDTFs. In the example, the locus encoding an LDTF (e.g. BCL11B in early T-cell
development) is switched from the repressive B compartment to the transcription-competent A compartment under the influence of differentiation (Diff.) signals. As
the LDTF gene is activated in the A compartment, TF proteins are produced that initiate a transcriptional and topological rewiring of the lymphocyte precursor that
will eventually result in stable lineage commitment. LDTFs operate at different levels of 3D genome organization, including modifications to intra-TAD connectivity,
promoter–enhancer (prom.-enh.) interactions and A/B compartment switching.
vironment into a specific and spatially temporally controlled
transcriptional response. These changes in the cellular tran-
scriptome in turn lead to a modified proteome and, ultimately,
cell function(s).
Topological genome dynamics and lymphocyte biology
Lymphocyte commitment meets genome topology: B cells
In mammals, lymphoid progenitors can either remain in the
bone marrow, where they will differentiate toward B cells or
innate lymphoid cells, or they canmigrate to the thymus to initi-
ate T-cell differentiation. Here,we discuss how early lymphocyte
development is orchestrated at the transcriptional level and how
this connects to functional changes in genome topology. Given
the lack of systematic investigations of 3D genome organization
during the development of innate lymphoid cells, we restrict
ourselves to B and T lymphocytes.
Commitment of CLPs to the B-cell lineage is tightly controlled
by a regulatory network formed by the combinatorial action
of TFs PU.1, Ikaros, E2A, EBF1 and PAX5 [50]. EBF1 represses
alternative lineage programs (e.g. for natural killer cell differ-
entiation) and functions as a transcriptional activator of other
TF-encoding genes that are crucial for B-cell development, in
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particular PAX5, which stably locks in the B-cell fate at the
pro-B-cell stage (Figure 2A) [51–53]. Early B-cell development
is accompanied by substantial modifications to 3D genome
architecture. Already in 1997, Brown et al. showed that in pre-
B cells the actively transcribed gene λ5 does not associate with
heterochromatin-associated Ikaros foci, while its silencing in
mature B cells correlates with close nuclear proximity of the
locus to heterochromatin-associated Ikaros complexes. The
Cd2 locus shows the opposite dynamics: it moves away from
heterochromatin-associated Ikaros foci concomitant with its
upregulation inmature B cells [54].More recently, Lin et al. report
hundreds of genes switching between A and B compartments
when pre-pro-B cells differentiate to pro-B cells [55]. Notably,
the Ebf1 locus repositions from the B compartment at the
nuclear lamina to the A compartment, concomitant with its
transcriptional activation in pro-B cells [55]. Other loci that
shift from B to A at this early stage include Foxo1 and the Ig
light chain loci, which in general correlates with increased
mRNA expression. Genes that switch without transcriptional
upregulation are often marked by the repressive histone
modification H3K27me3, suggesting they are actively repressed
independent of their nuclear sublocalization [55]. Within these
compartments, TF-binding sites frequently colocalize in nuclear
space—even over large distance (>1 Mb). Interestingly, two
separate classes of such TF-interaction hubs have emerged [55].
One consists of (shorter-range) interactions between CTCF and
cohesin-complex sites, which form through loop extrusion and
represent many of the cell-type invariant structural loops in the
genome [9, 17]. Another involves strong long-range interactions
between B-cell TFs (e.g. E2A, PU.1) and the enhancer-binding
histone acetyltransferases P300, indicating the existence of cell
type-specific 3D-organized hubs of REs.These TF-mediated hubs
have also been detected in other cell types, where they may
safeguard cell identity or even help establish new identities by
optimizing the regulation of TF target genes [18, 56]. Hence, TFs
appear not only to mediate changes in gene expression and
chromatin state, but also rewire the 3D genome during early
B-cell development. In line with this, the binding landscape
of E2A is dramatically altered as pre-pro-B cells differentiate
to pro-B cells [57]. E2A colocalizes on the chromatin with
other key regulators of early B-cell development, including
EBF1 and FOXO1, suggesting their collaborative control of B-
cell commitment [57]. Similarly, EBF1 DNA-binding is observed
at approximately 30% of known PAX5-regulated genes, which
is a two-fold enrichment over an unrelated control gene set
[58]. We propose that the cooperative action of TFs during B-
cell development allows for stricter control of 3D chromatin
interactions involved in transcriptional regulation, which
require specific combinations of TFs in order to be formed or
maintained.
PAX5 enforces final B-cell commitment by repressing
alternative lineage programs and activating a new subset of
B-cell-specific genes [59]. Over 50% of PAX5 binding sites are
located outside of genes or promoters [60], suggesting that
PAX5 mainly uses long-range enhancer-promoter interactions
to execute its function. Indeed, Hi-C analyses of Pax5−/− pro-
B cells by Johanson et al. reveal 7810 differential chromatin
interactions compared to WT pro-B cells; 83% of these nuclear
proximities are weakened or removed in the mutant Pax5−/−
cells [60]. Importantly, cDNA-mediated PAX5 re-introduction
partially rescues aberrant 3D genome folding in Pax5−/− B-
cell progenitors. While the loss of PAX5 has minimal effects
on A–B compartmentalization and global TAD architecture
[60], it appears that PAX5 mediates local intra-TAD regulatory
interactions (e.g. promoter-RE contacts) to enforce B-cell lineage
commitment. Importantly, the presence of PAX5 modifies 3D
chromatin architecture in a seemingly direct manner that is
independent of ongoing transcription: treatment of pro-B cells
with α-amanitin (a potent inhibitor of RNAPol2) did not prevent
PAX5 from rescuing the majority of chromatin interactions in
Pax5−/− cells [60]. Johanson et al. also used Hi-C to analyze global
3D genome configuration of various B-cell subsets, including
splenic B-cell populations, activated B cells and plasma cells.
Intriguingly, while modifications to genome topology occur
during every state transition, 3D genome dynamics peak after
Pax5 induction and upon mature B-cell activation [60]. Thus,
rewiring of 3D chromatin folding positively correlates with B-cell
lineage commitment (i.e. the presence of PAX5) and activation in
tissues (Figure 2B).
Lymphocyte commitment meets genome topology: T cells
T-cell development takes place in the thymus, which is seeded
by early thymic progenitors that represent the double negative
(or ‘DN’, because of the absence of the two canonical T-cell
lineage markers CD4 and CD8) stage of T-cell development.
Guided by Notch signaling and the activation of the lineage-
determining TF BCL11B, definitive T-cell lineage commitment
is enforced. Productive TCR rearrangements allow developing T
cells to progress to the double positive (DP) stage and ultimately
to CD4+ or CD8+ mature naive T cells (Figure 2A) [61, 62].
BCL11B, much like the key early B-cell TF PAX5, is critical for
the silencing of alternative lineage programs in DN cells [61],
in line with the substantial enrichment of BCL11B binding
to regions with the repressive H3K27me3 mark [63]. Bcl11b
activation is dependent on the stepwise combinatorial action of
NOTCH and its downstream TF RBPJκ, the NOTCH-regulated TFs
GATA3 and TCF1, as well as RUNX1, which operate at both the
Bcl11b promoter region and an essential T-cell-specific enhancer
located 850 kb downstream [64].
Another parallel with B-cell development is that the Bcl11b
locus, like Ebf1, repositions from the B compartment in multi-
potent hematopoietic progenitors to the A compartment during
early DN T-cell differentiation. This transition, which occurs
concomitantly with Bcl11b gene activation, is mediated by tran-
scription of a non-coding RNA called thymocyte differentiation
factor (ThymoD) [65]. Furthermore, in the absence of ThymoD
transcription, chromatin loops between the Bcl11b promoter and
its distal enhancers are not formed, resulting in reduced Bcl11b
expression and developmental arrest. Isoda et al. have shown
that Bcl11b nuclear localization and 3D chromatin organiza-
tion by ThymoD transcription occurs through the demethyla-
tion of CpG residues that facilitates the recruitment of CTCF
and cohesin. Binding of CTCF-cohesin then promotes promoter–
enhancer proximity and switching of the locus toward the A
compartment [65].
At a genome-wide level, early T-cell development is accom-
panied by frequent A–B compartment switching, involvingmany
loci encoding key TFs such as Bcl11b (B-to-A switching) andMeis1
(encoding a TF essential for multipotent hematopoietic precur-
sors that is silenced and subjected to A-to-B switching) [63]. TAD
border numbers vary during T-cell development (between 2768
and 3765 depending on the time point), and Hu et al. observed
substantial intra-TAD interaction dynamics as cells differentiate
toward the DP stage [63]. Again, 3D genome dynamics peak at
the onset of lineage commitment, coinciding with upregulation
of Bcl11b (Figure 2B). Like the B-cell commitment factor PAX5,
BCL11B itself appears directly involved in this remodeling of
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the 3D chromatin landscape by promoting long-range chromatin
interactions for its direct target genes, thus increasing their
intra-TAD connectivity and expression levels [18, 23, 63].
From these combined analyses of B-cell and T-cell devel-
opment, a picture emerges that intimately links the activity
of lineage-determining TFs such as BCL11B, PAX5 and EBF1 to
shaping lymphocyte genome topology. Loci encoding lympho-
cyte commitment TFs reside in the B compartment, possibly
to help prevent their promiscuous activation. Differentiation
signals from the microenvironment ‘liberate’ these TF loci, acti-
vating their expression and positioning them into the A com-
partment. The protein products of the now actively transcribed
lineage-determining TF genes start to explore the nucleus in
search for their target sequences, reshaping the 3D chromatin
landscape at various levels to achieve proper gene activation and
repression (Figure 2C). In line with analyses from other differen-
tiation trajectories, the reported rewiring of the 3D chromatin
landscape during the stepwise development of T cells generally
coincides with major changes in histone modifications, global
DNA accessibility and gene expression. However, changes in
genome conformation can follow (i.e. for A-to-B switching) or
foreshadow (i.e. for increased intra-TAD connectivity) transcrip-
tional dynamics [63], indicating that gene regulation and 3D
genome organization are not always strictly coupled during
lymphoid development.
Antigen-receptor rearrangement requires dynamic 3D
chromatin folding
Antigen-receptor recombination is restricted to specific lym-
phocyte lineages and developmental stages (Figure 2A). This
specificity is in part controlled by the regulated expression of
the RAG1/RAG2 recombinase complex in non-dividing immature
lymphocytes and its recruitment to only a small focal region of
active chromatin at the 3′ end of each antigen-receptor locus
called the ‘recombination center’ [39]. Additionally, the timing
of ordered V(D)J recombination, i.e. (i) D-to-J rearrangements
preceding V-to-DJ rearrangements at the Igh/TCRβ loci and (ii)
Igh/TCRβ recombination occurring before Igl/TCRα recombina-
tion, can be explained by the developmentally timed non-coding
transcription of VDJ gene segments (referred to as ‘germline
transcription’). Transcribed gene segments are specifically
accessible to the recombinase [66]. Although the molecular
mechanisms underlying this ‘accessibility hypothesis’ remain
somewhat unclear, it has become apparent that the recruitment
of developmental-stage-specific TF combinations to VDJ
gene promoters and enhancers is critical for gene segment
accessibility [67].
Antigen-receptor loci can span very large genomic distances
(>1Mb) and contain hundreds of V gene segments, each ofwhich
needs to have an equal opportunity to be used for recombination.
Then, how are the very distal V genes—some of which are 2.5 Mb
away from the recombination center—able to interact with the
recombinase? Why do these different distances of individual V
genes to the recombination center not result in a preference for
proximal over distal V gene usage? It turns out that the answer to
this lymphocyte-specific problem lies in the chromatin confor-
mation of antigen-receptor loci at the time of or prior to recom-
bination. To correct for the decreasing chance of a given V gene
segment to interact with the recombination center as its linear
genomic distance increases, megabase-sized antigen-receptor
loci undergo extensive 3D chromatin compaction or ‘locus con-
traction’ (Figure 3) [68]. This way, all gene segments will have
a largely similar average spatial distance to the recombination
center, which ensures equal opportunities for recombination
andmaximum antigen-receptor repertoire diversity (for a recent
more in-depth review, see Johanson et al. [69]).
Hi-C analyses of developing B cells have revealed that the
Ig loci are contained within TADs [70, 71]. Prior to their recom-
bination, the Igh and Igl loci undergo a B-to-A compartment
switch that positions them away from the nuclear lamina [55,
72]. Simultaneously, a marked gain in long-range interactions
within the Ig-locus TADs indicates active locus contraction [55,
73]. Although the forces driving locus contraction at antigen-
receptor loci are only partially understood, they appear similar
to those involved in shaping chromatin conformation related
to canonical transcriptional regulation. The concerted action
of cell-type-specific TFs (e.g. PAX5, E2A) and general structural
factors (i.e. CTCF, YY1) bound throughout the locus is critical
for achieving optimal contraction and antigen-receptor diversity
[67]. For example, depletion of PAX5 or CTCF during early B-cell
development leads to altered long-range chromatin interactions
and reduced contraction at Ig loci, resulting in impaired or prox-
imally skewed recombination [74–76]. In this context, TFs can
induce optimal locus contraction in a stepwisemanner [72]. Prior
to recombination, E2A is recruited to the enhancers of the Igκ
locus to initiate its contraction in pro-B cells via largely random
interactions with the V gene region. Subsequent differentiation
into pre-B cells activates additional TFs, including IRF4, that
also bind the Igκ enhancers and trigger a highly coordinated
pattern of enhancer–gene interactions (‘enhancer focusing’) that
strongly correlates with V gene recombination frequencies [72].
Lymphocyte activation and genome topology
After their development into mature lymphocytes, naive B and
T cells enter the circulation. Once they encounter their cognate
antigen and the right set of costimulatory signals, lympho-
cytes rapidly activate to initiate their specification into effector
or memory cells. Lymphocyte activation triggers a dramatic
phenotypic transformation that involves large-scale changes in
gene expression accompanied by increased proliferation and a
unique metabolic profile to accommodate the increased energy
demands [77–79].
Regarding the role of the 3D chromatin landscape in this
context,CD4+ Thelper (Th) cell activation has been studiedmost
extensively. T-cell activation requires TCR stimulation through
presentation of an antigenic peptide by antigen-presenting cells
(signal 1); a costimulatory signal, often via the T-cell surface pro-
tein CD28 (signal 2); and soluble factors (i.e. cytokines) released
by the antigen-presenting cell or present in the microenviron-
ment (signal 3). Together, these signals imprint Th-subtype dif-
ferentiation and tissue-homing capacities onto the activated T
cell [46, 80]. Depending on the specific combination of signals,
CD4+ T cells will differentiate into one of the main Th subtypes:
Th1 cells that express the TF T-bet and produce interferon-
gamma (IFNγ ) to combat intracellular pathogens; Th2 cells that
express GATA3, and produce IL-4, IL-5 and IL-13 to clear para-
site infections; Th17 cells that rely on the RORγ TF and pro-
duce IL-17 to respond to extracellular pathogens; or regula-
tory T cells (Tregs) that synthesize the TF FOXP3 and secrete
anti-inflammatory cytokines such as IL-10 [80]. Important to
note here is that differentiated Th cells can show considerable
phenotypic plasticity, including (semi) stable intermediates (e.g.
‘Th17.1’ cells)42. Thus, environmental signals activate a spe-
cific lineage-determining TF that, together with other signal-
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Figure 3. Locus contraction at antigen-receptor loci maximizes receptor diversity. Megabase-sized antigen-receptor loci (e.g. the murine immunoglobulin kappa locus
shown here) are organized in TADs. Differentiation signals induce B-to-A compartment switching of the locus and trigger the establishment of a 3′-end recombination
center near the (D-)J elements. At the recombination center, B-cell transcription factors (TFs) create an active chromatin environment that facilitates the recruitment
of the RAG1/RAG2 V(D)J recombinase. To ensure equal average proximity of all V genes to the recombination center, antigen-receptor loci ‘contract’ to create a compact
3D structure that provides largely equal opportunities for every V gene to be recombined.
responsive TFs (e.g. STATs), induces a cell-fate change involving
widespread transcriptional remodeling.
Focused analyses of how these TFs activate the abovemen-
tioned Th signature cytokine-encoding loci have revealed that
local 3D chromatin architecture plays a key role in establish-
ing long-range promoter–enhancer communication and shap-
ing Th-cell identity. A prime example is the activation of the
clustered Il4, Il5 and Il13 genes (together often referred to as the
‘Th2 locus’) during Th2 differentiation. 3C analyses by the Flavell
laboratory showed that while the Il4, Il5 and Il13 gene promoters
spatially cluster in every cell type tested, the enhancer ele-
ments (organized in a locus control region or LCR) only interact
with these gene promoters in T cells [81]. Surprisingly, LCR-
promoter clustering also occurs—albeit somewhat weaker—in
naive T cells or Th1 cells where this locus is inactive, suggesting
that genome topology poises the Th2-cytokine genes for rapid
activation in the presence of additional factors [81]. Remarkably,
GATA3 overproduction and ionomycin-induced Nuclear factor
of activated T cells (NFAT) activation induced LCR-promoter
interactions even in fibroblasts [81], directly implicating these
TFs in establishing promoter–enhancer communication. By con-
trast, interactions between the Ifng promoter and its enhancer
elements are only detected in Th1 cells and depend on the pres-
ence of T-bet [82]. At the level of nuclear compartments, early
microscopy studies showed that Th1 differentiation is accom-
panied by a progressive repositioning of Th2-associated genes
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Figure 4. Integration of multiple signals activates a set of transcription factors that together establish the specialized 3D chromatin landscape of effector lymphocytes.
Naive B and T lymphocytes require a combination of three signals (1: antigen-receptor ligation, 2: costimulation, 3: cytokines) for their full activation. These three
signals will activate signal-responsive TFs (e.g.NFAT,AP-1, STAT),whichwill in turn activate lineage-determining TFs (e.g. GATA3,T-bet) that together initiate topological
genome remodeling in a concerted manner. The resulting specialized 3D chromatin landscape that arises is tailored to the specific microenvironmental input received
by the lymphocyte. Of note, complete topological remodeling by TFs appears to require all three signals. Additional abbreviations: BCR; TCR
toward centromeric heterochromatin [83, 84]. Together, these
findings point toward a highly dynamic spatial organization of
key cytokine and TF loci during CD4+ Th-cell activation.
Long-range chromatin interactions of the Il4 and Ifng genes
in Th1 and Th2 cells have also been investigated in a genome-
wide manner using 4C [85]. Promoter ‘interactomes’ for these
two genes show substantial Th-subset specificity. Highly inter-
acting genes also show higher subset-specific expression levels
and these interaction partners are enriched for other immune-
related genes. Althoughmost interactions with the Ifng promoter
can also be detected in naive T cells, many interactions become
more focused (i.e. sharper, more narrow signals) upon Th1 spec-
ification, indicating a shift from promiscuous to more selective
3D genome architecture. Interestingly, 3D genome dynamics
correlate with binding of STAT TFs that are activated by specific
differentiation signals; the Th1-inducing cytokine IL-12 activates
STAT4, while the Th2-inducing cytokine IL-4 activates STAT6. Th
cells from Stat knockout mice failed to shed the promiscuous
interactions with Ifng and Il4, indicating a direct role for signal-
responsive TFs—alongside the TFs they themselves activate, e.g.
T-bet or GATA3—in shaping lymphocyte genome topology [85].
Importantly, this work shows that TCR-mediated signaling and
costimulation alone (signals ‘1’ and ‘2’, which are intact in STAT-
deficient Th cells) are not sufficient to establish Th-subset-
specific 3D chromatin architecture. Thus, we postulate that the
canonical three signals required for T-cell activation (see above)
together ensure a highly specialized TF-mediated rewiring of
genome topology tailored to specific microenvironmental cues
(Figure 4).
The findings discussed above strongly suggest that the 3D
regulation of gene expression is important during lymphocyte
activation, at least at key effector gene loci. More recently,
studies have started to investigate genome-wide chromatin
conformation dynamics during the activation and effector
differentiation of individual lymphocyte subtypes. Promoter
capture Hi-C (PCHi-C) of 17 types of primary human blood cell
showed that not only the different cell types, but also naive
versus activated lymphocytes can be separated based on their
specific promoter-interactomes [22]. Javierre et al. showed that
only 55% of interactions are shared between resting CD4+ T
cells and activated CD4+ T cells after 4 h stimulation with
anti-CD3 and anti-CD28, while 22% are specific for resting and
23% for activated CD4+ T cells. Promoter–enhancer interactions
positively correlate with increased gene expression [22], which
was confirmed in a second PCHi-C study comparing resting and
activated human peripheral blood CD4+ T cells [86]. Another
study employed H3K27ac Hi-ChIP (to specifically interrogate
chromatin interactions between H3K27ac+ active REs) to
compare human peripheral blood CD4+ naive T cells, Th17 cells
and Tregs. Likewise, interactions involving active regulatory
regions are highly subtype-specific and strongly correlate to
differential expression of the genes involved [87]. Enhancers
involved in subset-specific interactions are enriched for known
and unknown TF motifs, most notably RORγ in Th17-specific
loops and FOXP3 in Treg-specific loops. Importantly, 62.2–
85.8% of subset-specific loops display equal DNA accessibility
across the individual T-cell subsets, suggesting that subset-
specific differential gene expression programs are not only
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achieved through differential chromatin accessibility but also
via differential TF-mediated chromatin looping [87]. In Jurkat
cells, a human leukemic T-cell line carrying a competent TCR,
most early responder genes such as CD69 and IL2RA, are already
localized within the nuclear interior prior to activation [88].
Upon activation, 4% of the genome (approximately 5000 regions
containing over 1300 genes) is either released from the lamina
into the nuclear interior or vice versa. A subset of lamina-
released genes also shows increased expression, includingmany
known regulators of T-cell responses such as the cytoskeleton
regulator guanylate binding protein, the proliferation-inducing
cytokine IL2 and immune modulating receptors CD200 and
BTLA [88]. This combination of early response genes pre-
positioned in the nuclear interior together with activation-
induced release from the lamina of later response genes may
provide the necessary balance between rapid response capacity
and prevention of promiscuous activation, which is key for
maintaining immune homeostasis.
Activation of naive B cells triggers their migration to ger-
minal centers within secondary lymphoid organs (i.e. lymph
nodes or spleen). Germinal center B cells receive T-cell help,
proliferate extensively and undergo full activation and matura-
tion, eventually leaving the germinal center as active antibody-
producing plasma cells or memory cells [79]. Similar to T cells,
B-cell activation requires a combination of three signals and is
accompanied by global changes in transcriptome and chromatin
landscape. In line with this notion, murine B-cell activation
triggers amarked increase in 3D genome rewiring (Figure 2B) [60,
89, 90]. More specifically, B-cell activation requires the TF MYC
and involves a striking shift from long-range to short-range chro-
matin interactions that depend on ATP availability, resulting in
weakened A/B compartmentalization and an increase in CTCF-
mediated loops as well as promoter–enhancer interactions [89,
90]. These observations are in line with the global chromatin
decompaction and increased nuclear size of activated B cells [89,
90]. This dramatic shift in nuclear organization reduces TF-target
search times, providing activated germinal center B cells with a
nuclear micro-environment optimal for the reported rapid 10-
fold amplification of the B-cell transcriptome upon activation
[90]. Illustrative for the multiscale rewiring of genome topology
during B-cell activation is the BCL6 locus, which encodes a TF
specifically expressed in and essential for activated germinal
center B cells (Figure 2A) [91]. Upon activation, the BCL6 pro-
moter rapidly engages in elevated contact frequencies with its
enhancers but also the promoters of other rapid response genes.
Additionally, the BCL6 promoter initiates interactions with its
own 3’-UTR region upon B-cell activation, which is proposed to
facilitate reloading of RNAPol2 after transcription has completed
[89]. Together, these findings suggest that 3D genome remodel-
ing during B-cell activation is required to boost and efficiently
coordinate the transcription of a specialized gene expression
program, enabling germinal center B cells to rapidly modify
their proliferative andmetabolic capacity. Although MYC plays a
critical role in this process, it remains to be determined whether
the TF plays a direct role in reorganizing B-cell genome topology.
Conclusions and perspectives
Recent advances have demonstrated that cell fate, gene expres-
sion and genome topology are intimately connected. Lympho-
cytes do not seem to be an exception, as modifications to gene
expression during their development or activation strongly cor-
relate with specific changes at various levels of 3D genome orga-
nization. However, many important questions remain unsolved.
Do specific 3D genome conformations play an instructive role
in lymphocyte specification or activation? For example, are the
changes in nuclear positioning and local topology of the BCL11B
locus a cause or consequence of its induced expression at the DN
T-cell stage? Addressing this will require the controlled induc-
tion or perturbation of chromatin interactions, e.g. using CRISPR-
Cas9 based mutagenesis approaches [92]. Another important
topic for future studies is to elucidate the functional role of
TFs in (re)shaping genome topology at various scales. While
numerous studies have pointed toward a pivotal role of both
signal-responsive as well as lineage-determining TFs in estab-
lishing cell-type specific chromatin interactions, we still lack
a mechanistic understanding of this process. Also of interest
will be to study 3D genome dynamics during the activation of
innate lymphoid cells, which perform similar effector functions
as T cells, but respond to different signals and with different
kinetics [42].
Finally, we would like to emphasize the potential relevance
of genome topology for our understanding of human disease
in general. Studying disease-associated DNA variants—which
are strongly enriched in distal REs [93]—or larger chromoso-
mal abnormalities in the context of 3D chromatin architecture
can pinpoint misregulated genes and identify molecular mech-
anisms underlying disease [94]. As protocols for studying 3D
genome organization are rapidly maturing and can now deliver
high-resolution data using relatively small populations of cells
[95], we expect analyses of genome topology to become an
integral part of studying aberrant transcriptional control in the
context of immune disorders, leukemia and cancer immuno-
surveillance.
Key points
• 3D genome dynamics are intimately linked to gene
expression changes and peak during lineage commit-
ment and early after naive lymphocyte activation.
• Signal-dependent (e.g. STATs) and lineage-determining
(e.g. PAX5, BCL11B) transcription factors act synergisti-
cally to modify chromosome conformation at multiple
levels of organization.
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